🦊/Investors

View VenturesFull Portfolio

5 tracked investments · listed companies and verified rows first

Brius'brius.com

Brius (Brava) makes orthodontic teeth-straightening technology using its Independent Movers system, which it integrates with orthodontic practices.

HardwareHealthtechMedical Devices

Mehdi Peikar(Founder)in

Co-investorsCheyenne VenturesEvolution VC PartnersSand Hill AngelsTech Wildcatters

Euphrates Vasculareuphratesvascular.cominAug 2018

Euphrates Vascular develops the Pulse NanoMED System, a nanoscale interventional medical device that uses magnetically guided iron-oxide nanoparticles to reach and disrupt distal vascular occlusions beyond the reach of wires and catheters.

BiotechHealthtechMedical DevicesSt. Louis, US

Troy Long(Executive Officer)Jeffrey Blair(Director)Tim Blair(Executive Officer)inEric Moessinger(Director)Robert Mitchell(Director)Thomas Hillman(Director)

Co-investorsMissouri Technology CorporationOSF VenturesCultivation Capital

Rivermarkrivermarkmedical.comin

Rivermark Medical develops FloStent, a first-line device for treating benign prostatic hyperplasia (BPH) that is delivered during routine outpatient cystoscopy for urology practices and their patients.

HealthtechMedical DevicesMilwaukee, US

Anand Doraiswamy(Executive Officer, Director)Adam Kadlec(Co-founder)in

BoardScott Button(Director)Carter Meyer(Director)Matthew Ercolani(Director)Josh Baltzell(Director)

Co-investorsAndera Partners

Spirairspirair.comin

HealthtechSouth San Francisco, US

Ben Bishop(Executive Officer, Director)inJames Kintzing(Executive Officer, Director)

BoardRob Binney(Director)Carter Meyer(Director)Kate Garrett(Director)in

Co-investors1809 CapitalSonder Capital

Versa Vascularversavascular.cominDec 2025 · $27.3M

Versa Vascular is developing a tricuspid valve repair device with a delivery system designed for precise, repositionable implant placement.

HealthtechMedical DevicesSanta Cruz, US

Co-investorsSanta Cruz VentureBioStar CapitalCadence Healthcare VenturesS3 Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.